Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, et al. Bevacizumab and paclitaxel-carboplatin che- motherapy and secondary cytoreduction in recurrent, platinum- sensitive ovarian cancer (NRG Oncology/Gynecologic OncologyGroup study GOG-0213): a multicentre, open-label, randomised,phase 3 trial. Lancet Oncol.